As of 2026-01-05, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (14.27) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -440.5%.
The range of the Relative Valuation is (10.73) - (17.85) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.8x - 13.1x | 10.4x |
| Forward P/E multiples | 7.8x - 13.0x | 10.4x |
| Fair Price | (10.73) - (17.85) | (14.27) |
| Upside | -356.1% - -526.0% | -440.5% |
| Date | P/E |